| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > What is the Best Incentive? |
|
Advice You - What is the Best Incentive?
Incentive schemes have been much criticised in recent years, and it is quite true that some schemes have been singularly unsuccessful. Their failure, however, has often been the result of inadequate planning, rushed introduction, or not thinking through such a scheme properly. These points should n According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ot be used to generally condemn other more successful applications. Whether any particular incentive scheme achieves long term success depends initially on the thoroughness with which the current working situation is reviewed, hence the need to re-look at some key Action Points, and question why y ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ou need an incentive scheme. 1. Increase in earnings for employees? 2. Increase in output? 3. Improvement in quality? 4. Better mobility of labour? 5. More efficient methods of working? 6. Improvement in safety? 7. Higher housekeeping standards? 8. Reduction in a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. bsenteeism? 9. Reduction in labour turnover? 10.Reduction in overtime working? Any of these points or a combination, will determine how you introduce and communicate such a scheme. The following questions will act as an “aide memoire”. 11. Does the work necessitate skilled, semi-skilled here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe or unskilled labour? 12. Can individual skill be fully applied when manipulating machines etc. or is the employee’s quantity and quality of output regulated to a large extent by factors outside his/her control? 13. Does the level of output remain steady throughout the year or is it subject to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro seasonal variations? 14. Is production organized on a process flow line, batch or jobbing basis? 15. Have your current production methods been recently reviewed for maximum efficiency? 16. Is any new machinery or plant, to be introduced in the near future, likely to upset the standard upon whic ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc h an incentive scheme might be based? 17. Have you sufficient qualified staff to introduce an incentive scheme, or alternatively, have you one qualified employee who is capable of training other staff in work study techniques? 18. Once the scheme is introduced, will you have the necessary number easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi f staff to be able to keep it under constant review, and to introduce modifications where necessary? 19. Will the present staff in the wages department be able to cope with bonus calculations etc. without additional help? 20. Are other parts of the organization such as Production Control, Mainten nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ance, Distribution etc. geared to cope with the increased flow of materials and output that are likely to result? 21. Are your present channels of communication, both formal and informal, capable of coping with the dissemination of detailed information to all employees, on the workings of any prop and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ osed incentive plan? 22. Have you the necessary facilities, away from the production area, for any operative training or re-training that might be required? 23. Have you agreed the principle of using work measurement with the trade unions and employee representatives? 24. Will you be undertaking ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the training of any employee representatives in work study techniques? 25. Are the mechanics of your scheme simple enough to enable all employees to fully understand how their pay is calculated? 26. What standards will you use to evaluate performance to ensure that a proper balance is maintained ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a between: a. Increased output b. Maintaining quality c. Efficient use of equipment or materials? 27. How will you relate payment to performance? e.g. in direct proportion to output? 28. On what length of time will you base payment? e.g. hour, shift, week? 29. Will you gear the scheme to the in dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod dividual, working group, department or factory? 30. Will you apply the scheme in some way to direct as well as indirect personnel? If not, how will the problem of increased or decreased differentials be solved? 31. Will official disputes concerning the operation of the incentive plan be handled t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hrough the normal negotiating and disputes machinery? 32. What will be the principles governing payment for ‘waiting time’ or unmeasured work? 33. Will any scheme you introduce be on a gradual basis or do you intend to apply it to all appropriate sections at the one time? 34. How will you calcu tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ate holiday pay for pieceworkers? It’s notoriously difficult to put together an incentive scheme that motivates all of its targets, and that continues to do so over an extended period. You may be looking to get the most from your staff by increasing motivation, improving morale and encouraging eff t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel iciency. Incentive awards are a way of rewarding employees and others with cash, goods or holidays rather than increases in pay. There are Two Basic Types Of Incentive Scheme, Financial and Non-Financial Schemes can vary from national promotions to a prize raffle held by a small firm. Rewards o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust f goods or holidays will usually involve the use of a voucher. Awards may be linked to sales performance, good timekeeping, safety or production records, or may involve participation in a lottery or prize draw. There should be increasing consistency in the ways that reward, recognition and incent y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ves are offered to customers, staff and distributors. Participants should always have the power of choice, enabling them to self-target and work towards things that are exciting or important to them. Incentives that are always won by a small group of high performers, breed more resentment than mot . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ivation, while the high performers themselves soon become bored with the repetition of holidays, and activities that are open to them. The aim of an incentive scheme is to improve the performance of your business, whether it is your employees, customer's or supply chain. As a result the most succ elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip essful incentive schemes tend to be those matched to the individual's requirements, but which still appeal to the company as a whole. You will find that with a little extra thought, allied to a willingness to be creative, can make a quantum difference to the effectiveness of an incentive programme tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Listening When You Don't Want To The Past, The Present, And The Future: A Compulsive Gambler's Thoughts Through Poetry Part 3 How Dishonest is Your Competition?
|